Compare RUSHA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUSHA | DYN |
|---|---|---|
| Founded | 1965 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.4B |
| IPO Year | 1996 | 2020 |
| Metric | RUSHA | DYN |
|---|---|---|
| Price | $62.95 | $17.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 17 |
| Target Price | ★ $58.00 | $39.94 |
| AVG Volume (30 Days) | 364.0K | ★ 2.1M |
| Earning Date | 02-17-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.37 | N/A |
| Revenue | ★ $7,671,888,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.26 | N/A |
| P/E Ratio | $18.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $45.67 | $6.36 |
| 52 Week High | $66.11 | $25.00 |
| Indicator | RUSHA | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 67.39 | 48.05 |
| Support Level | $58.63 | $16.00 |
| Resistance Level | $66.11 | $17.50 |
| Average True Range (ATR) | 1.85 | 0.95 |
| MACD | 0.54 | 0.03 |
| Stochastic Oscillator | 73.30 | 51.92 |
Rush Enterprises Inc is a full-service, integrated retailer of commercial vehicles and related services. The company operates in a single segment; Truck Segment includes the operation of a network of commercial vehicle dealerships under the name Rush Truck Centers. It sells commercial vehicles manufactured by Peterbilt, International, Hino, Ford, Isuzu, IC Bus, and Blue Bird and also provides one-stop service for the needs of commercial vehicle customers, including retail sales of new and used commercial vehicles, aftermarket parts sales, service and repair facilities, financing, leasing and rental, and insurance products. The company's business is concentrated in the United States and Ontario, Canada commercial vehicle markets and related aftermarkets.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.